Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 4/2011

01-08-2011 | Review Article

Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity

Authors: Luca Errichiello, Salvatore Striano, Federico Zara, Pasquale Striano

Published in: Neurological Sciences | Issue 4/2011

Login to get access

Abstract

Epilepsy is one of the most impactful diseases on social life. A significant number of epileptic syndromes have been linked to immunological alterations. Elevated levels of antibodies against glutamic acid decarboxylase have been recently found in a significant percentage of patients with temporal lobe epilepsy, the most common epilepsy type. The clinical and pathogenetic relationship of this association is discussed. This link may have important therapeutic implications and merits additional clinical and laboratory research.
Literature
1.
2.
3.
Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, Cavalcanti D, Baulac M (1998) Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51(5):1256–1262PubMed
4.
Kwan P, Brodie MJ (2003) Clinical trials of antiepileptic medications in newly diagnosed patient with epilepsy. Neurology 60(11 Suppl 4):S2–S12PubMed
5.
Billiau AD, Wouters CH, Lagae LG (2005) Epilepsy and the immune system: is there a link? Eur J Paediatr Neurol 9(1):29–42PubMedCrossRef
6.
Bernasconi P, Cipelletti B, Passerini L, Granata T, Antozzi C, Mantegazza R, Spreafico R (2002) Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients’ sera. Neurology 59(12):1998–2001PubMed
7.
van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H (1994) Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res 19(3):181–190PubMedCrossRef
8.
Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131(Pt 10):2553–2563PubMedCrossRef
9.
Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keränen T, Graus F (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55(1):46–50PubMed
10.
Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF (1998) Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 352:457PubMedCrossRef
11.
Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S, Zara F, Striano P (2009) Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 211(1–2):120–123PubMedCrossRef
12.
Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM, Dastidar P, Knip M, Saiz A, Peltola J (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51(5):760–767PubMed
13.
Sokol DK, McIntyre JA, Wagenknecht DR, Dropcho EJ, Patel H, Salanova V, da Costa G (2004) Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy. Neurology 62(3):517–518PubMed
14.
15.
Faulkner-Jones BE, Cram DS, Kun J, Harrison LC (1993) Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat. Endocrinology 133(6):2962–2972PubMedCrossRef
16.
Bu DF, Tobin AJ (1994) The exon-intron organization of the genes encoding two human glutamate decarboxylases (GAD65 and GAD 67) suggests that they derive from a common ancestral GAD. Genomics 21:222–228PubMedCrossRef
17.
Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K (1997) Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94(12):6496–6499PubMedCrossRef
18.
Hong J, Heng W, Gregory O, Jianning W, Kathleen D, Di S, Eric F, Che-Chang H, Richard DK, Jang-Yen W (2003) Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. PNAS 100:4293–4298
19.
Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S (1997) Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94(25):14060–14065PubMedCrossRef
20.
Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555–1560PubMedCrossRef
21.
Espay AJ, Chen R (2006) Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve 34(6):677–690PubMedCrossRef
22.
Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55:1531–1535PubMed
23.
Sperber EF, Velísková J, Germano IM, Friedman LK, Moshé SL (1999) Age-dependent vulnerability to seizures. Adv Neurol 79:161–169PubMed
24.
Lloyd KG, Scatton B, Voltz C, Bryere P, Valin A, Naquet R (1986) Cerebrospinal fluid amino acid and monoamine metabolite levels of Papio papio: correlation with photosensitivity. Brain Res 363(2):390–394PubMedCrossRef
25.
Esclapez M, Trottier S (1989) Changes in GABA-immunoreactive cell density during motor focal epilepsy induced by cobalt in the rat. Exp Brain Res 76(2):369–385PubMedCrossRef
26.
Fritsch B, Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Rogawski MA, Braga MF (2009) Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis. Neuroscience 163(1):415–429PubMedCrossRef
27.
28.
Macdonald RL, Kelly KM (1995) Antiepileptic drug mechanisms of action. Epilepsia 36(Suppl 2):S2–S12PubMedCrossRef
29.
Vianello M, Tavolato B, Giometto B (2002) Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 23:145–151PubMedCrossRef
30.
Aykutlu E, Baykan B, Gürses C, Gokyigit A, Saruhan-Direskeneli G (2005) No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: a pilot study. Seizure 14(5):362–366PubMedCrossRef
31.
Striano P, Perruolo G, Errichiello L, Formisano P, Beguinot F, Zara F, Striano S (2008) Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes. Ann Neurol 63:127–128PubMedCrossRef
32.
Striano P, Errichiello L, Striano S (2011) Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy Behav 20:145PubMed
33.
Levy LM, Levy-Reis I, Fujii M, Dalakas MC (2005) Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol 62(6):970–974PubMedCrossRef
34.
Fishman PS, Drachman DB (1995) Internalization of IgG in motoneurons of patients with ALS: selective or nonselective? Neurology 45(8):1551–1554PubMed
35.
Vianello M, Bisson G, Dal Maschio M, Vassanelli S, Girardi S, Mucignat C, Fountzoulas K, Giometto B (2008) Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies. Autoimmunity 41(1):66–73PubMedCrossRef
36.
Vianello M, Keir G, Giometto B, Betterle C, Tavolato B, Thompson EJ (2005) Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies. Eur J Neurol 12:294–299PubMedCrossRef
37.
Vianello M, Giometto B, Vassanelli S, Canato M, Betterle C, Mucignat C (2006) Peculiar labeling of cultured hippocampal neurons by different sera harbouring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab). Exp Neurol 202:514–518PubMedCrossRef
38.
Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, Hilz MJ, Schellinger PD, Schwab S, Bardutzky J (2008) Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 49(5):914–920PubMedCrossRef
39.
Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, Bisulli F, Paganini M, Mazzi G, Sorbi S, Tinuper P (2008) Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 199(1–2):155–159PubMedCrossRef
Metadata
Title
Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity
Authors
Luca Errichiello
Salvatore Striano
Federico Zara
Pasquale Striano
Publication date
01-08-2011
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 4/2011
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0566-8

Other articles of this Issue 4/2011

Neurological Sciences 4/2011 Go to the issue

Case Report

Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis

Original Article

Expression of locus coeruleus mineralocorticoid receptor and glucocorticoid receptor in rats under single-prolonged stress

Original Article

Acute medical complications in patients admitted to a stroke unit and safe transfer to rehabilitation

Letter to the Editor

Early TCD monitoring in brain death: what may be relevant?

Case Report

An unusual growth of an intraventricular meningioma: a case report

Original Article

Prevalence of bifid median nerve at wrist assessed through ultrasound